# Cancer Epidemiology Research Program

> **NIH NIH P30** · UNIV OF NORTH CAROLINA CHAPEL HILL · 2021 · $45,064

## Abstract

ABSTRACT: CANCER EPIDEMIOLOGY PROGRAM
The Cancer Epidemiology program studies environmental, genetic, and molecular risks for cancer and cancer
outcomes to identify priorities for public health and clinical intervention. The program has three aims: (1) Risk-
Based Prevention and Early Detection: To identify opportunities for risk-based prevention and early detection
of cancer; (2) Treatment, Outcomes and Survivorship: To improve cancer treatment, outcomes, and
survivorship through epidemiologic and clinical research that leads to evidence-based interventions; (3)
Integrative Molecular Epidemiology: To deepen understanding of cancer etiology, heterogeneity, and
survivorship through integrative human molecular and histopathologic studies of precursor lesions and tumors.
A major cross-cutting theme is addressing the epidemiology of health disparities. As a comprehensive cancer
center in an economically, socially, and racially diverse state, CE is well-poised to address health equity.
Across these aims, we use multidimensional North Carolina studies and conduct cross-program research to
yield high impact findings. Members have expertise in population-based epidemiology, data linkage,
pharmacoepidemiology, survey research, clinical research, screening, molecular and biomarker research,
translational preclinical research, sociology, pathology, genomics, data science, computer science, and
statistical and epidemiologic methods. Research resources include population-based studies of breast, colon,
prostate, head and neck cancer as well as registries for breast and lung screening. Many of these studies
participate in large national and international data-sharing initiatives and consortia. The Program brings value
to the Center through study resources that collect exposure and outcome data, and biospecimens, a unique
shared resource (Statewide Cancer Data), and expertise in epidemiologic methods. The Program is supported
by UNC Lineberger’s investments in faculty recruitments, shared resources and developmental funds. The
UNC Lineberger strategic plan emphasis on optimizing cancer outcomes in North Carolina has led to
significant investment across population sciences and is expanding in new areas in coming years including
endometrium and bladder, with sustained support for ongoing data collection in breast cancer and head and
neck cancers. The CE Program consists of 33 members who are associated with 9 departments at UNC-
Chapel Hill and affiliated institutions. During the last funding period, program members have published 776
cancer-related articles, 24% were inter-programmatic and 19% were intra-programmatic (34%
collaborative). In 2019, our program members held grants totaling $10.0M (direct cost) in cancer-relevant
extramural funding, including $5.2M (direct costs) from the NCI and $3.0M other peer-reviewed funding.

## Key facts

- **NIH application ID:** 10089819
- **Project number:** 2P30CA016086-45
- **Recipient organization:** UNIV OF NORTH CAROLINA CHAPEL HILL
- **Principal Investigator:** Louise Henderson
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $45,064
- **Award type:** 2
- **Project period:** 1997-06-01 → 2025-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10089819

## Citation

> US National Institutes of Health, RePORTER application 10089819, Cancer Epidemiology Research Program (2P30CA016086-45). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10089819. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*